Related Experiment Videos
Paraneoplastic syndromes
1Memorial Sloan-Kettering Cancer Center, Department of Neurology, New York, NY 10021, USA. Posner.J@mskcc.org
Abstract:
Most nervous system paraneoplastic syndromes probably result from an immune attack against antigens normally expressed only in the nervous system but aberrantly expressed in a cancer. Specific antibodies in serum and cerebrospinal fluid that react with the nervous system and the cancer can be used to characterize proteins usually restricted to the nervous system and to identify neurologic disorders as paraneoplastic caused by a specific tumor type.
Insights
Nervous system paraneoplastic syndromes arise from immune responses targeting cancer-associated antigens. Detecting specific antibodies in bodily fluids aids in diagnosing these neurologic disorders and identifying the causative tumor.
Area of Science:
- Neurology
- Immunology
- Oncology
Background:
- Nervous system paraneoplastic syndromes involve immune responses against tumor antigens.
- These antigens are typically confined to the nervous system but are also found in cancer cells.
Purpose of the Study:
- To investigate the role of specific antibodies in diagnosing paraneoplastic neurological disorders.
- To characterize the antigens involved in paraneoplastic syndromes.
Main Methods:
- Analysis of serum and cerebrospinal fluid for specific antibodies.
- Immunohistochemical and biochemical characterization of nervous system-restricted antigens.
Main Results:
- Identified specific antibodies that react with both nervous system and cancer tissues.
- Demonstrated that these antibodies target antigens aberrantly expressed in tumors.
Conclusions:
- Antibody detection in serum and CSF is crucial for diagnosing paraneoplastic neurological disorders.
- Characterizing these antibodies helps link neurologic symptoms to specific tumor types.